Page 871 - Saunders Comprehensive Review For NCLEX-RN
P. 871

United States.
                                             2. Ophthalmic forms of erythromycin are prescribed
                                                because it is bacteriostatic and bactericidal and
                                                provides prophylaxis against Neisseria gonorrhoeae and
                                                Chlamydia trachomatis.
                                B. Use: As a prophylactic measure to protect against N. gonorrhoeae
                                   and C. trachomatis

                                        C. Interventions

                                             1. Clean the newborn’s eyes before instilling the
                                                medication.
                                             2. Do not flush the eyes after instillation.



                                                       Instillation of eye medication can be delayed for 1 hour after

                                                birth to facilitate eye contact and parent-newborn attachment and
                                                bonding.
                    XII. Phytonadione
                                A. Description
                                             1. The newborn is at risk for hemorrhagic disorders;
                                                coagulation factors synthesized in the liver depend on
                                                phytonadione (also known as vitamin K), which is not
                                                synthesized until intestinal bacteria are present.
                                             2. Newborns are deficient in phytonadione for the first 5
                                                to 8 days of life because of the lack of intestinal
                                                bacteria.
                                B. Use: Prophylaxis and treatment of hemorrhagic disease of the
                                   newborn
                                C. Adverse effect: Can cause hyperbilirubinemia in the newborn
                                   (occurrence is rare)

                                        D. Interventions

                                             1. Protect the medication from light.
                                             2. Administer during the early newborn period.
                                             3. Administer by the intramuscular route in the lateral
                                                aspect of the middle third of the vastus lateralis
                                                muscle of the thigh.
                                             4. Monitor for bruising at the injection site and for
                                                bleeding from the cord.
                                             5. Monitor for jaundice and monitor the bilirubin level
                                                because, although rare, the medication can cause
                                                hyperbilirubinemia in the newborn.
                    XIII. Hepatitis B Vaccine, Recombinant

                                        A. Description: Given intramuscularly to the newborn before

                                   discharge home
                                B. Use: Recommended for all newborns to prevent hepatitis B



                                                          871
   866   867   868   869   870   871   872   873   874   875   876